Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 6161–6180 of 17,529 recalls

December 18, 2019· MPRX, Inc. dba Medical Park Pharmacy

Recalled Item: Sildenafil 200 mg Troche (Clinic)

The Issue: Labeling: Incorrect or missing lot and/or expiration date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 18, 2019· MPRX, Inc. dba Medical Park Pharmacy

Recalled Item: Progesterone 50 mg capsules

The Issue: Labeling: Incorrect or missing lot and/or expiration date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 18, 2019· MPRX, Inc. dba Medical Park Pharmacy

Recalled Item: Liothyronine (T3) 92.5 MCG

The Issue: Labeling: Incorrect or missing lot and/or expiration date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 18, 2019· MPRX, Inc. dba Medical Park Pharmacy

Recalled Item: DHEA/Pregnenol One 10.25 MG Cap

The Issue: Labeling: Incorrect or missing lot and/or expiration date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 18, 2019· MPRX, Inc. dba Medical Park Pharmacy

Recalled Item: Tadalafil 20 mg Troche

The Issue: Labeling: Incorrect or missing lot and/or expiration date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 18, 2019· MPRX, Inc. dba Medical Park Pharmacy

Recalled Item: T3/T4 SR 9 mcg/38 mcg capsule

The Issue: Labeling: Incorrect or missing lot and/or expiration date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 17, 2019· Motto International Corp

Recalled Item: Rhino 7 Platinum 30000 Capsules

The Issue: Marketed without an Approved NDA/ANDA; FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
December 17, 2019· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Glenmark Ranitidine Tablets USP 150 mg Rx Only 500 Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 17, 2019· Motto International Corp

Recalled Item: Bull Platinum 30000 Capsules

The Issue: Marketed without an Approved NDA/ANDA; FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
December 17, 2019· Hikma Pharmaceuticals USA Inc.

Recalled Item: Ketorolac Tromethamine Injection

The Issue: Presence of Particulate Matter: particles identified as polydimethylsiloxane

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 17, 2019· Motto International Corp

Recalled Item: Stallion Platinum 30000 Capsules in blue

The Issue: Marketed without an Approved NDA/ANDA; FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
December 17, 2019· Motto International Corp

Recalled Item: Panther Platinum 30000 Capsules

The Issue: Marketed without an Approved NDA/ANDA; FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
December 17, 2019· Hikma Pharmaceuticals USA Inc.

Recalled Item: Ketorolac Tromethamine Injection

The Issue: Presence of Particulate Matter: particles identified as polydimethylsiloxane

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
December 17, 2019· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Glenmark Ranitidine Tablets USP 300 mg Rx Only 250 Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 17, 2019· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Glenmark Ranitidine Tablets USP 300 mg Rx Only 100 Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 17, 2019· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Glenmark Ranitidine Tablets USP 150 mg Rx Only 60 Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 17, 2019· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Glenmark Ranitidine Tablets USP 150 mg Rx Only 100 Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 17, 2019· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Glenmark Ranitidine Tablets USP 300 mg Rx Only 30 Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 16, 2019· Akorn Inc

Recalled Item: Hydrocortisone and Acetic Acid Otic Solution

The Issue: Subpotent Drug: Low Out of specification (OOS) assay

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 16, 2019· Pharmedium Services, LLC

Recalled Item: NORepinephrine Bitartrate 8 mg added to 500 mL 5% Dextrose

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund